Whitepaper: Patient-Focused Solutions for Higher Value Care in the Specialty Drug Market
This whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.
Nearly 75% of adults are nonadherent to prescription medications. The cost is estimated at $100-300 billion annually.
But do affordable and accessible patient-focused solutions exist?
This whitepaper illustrates how a commitment to connecting patients to their therapies and a sensitivity to the patient journey can make the difference between success and failure.
HIV Antiretroviral Reduced Alzheimer’s Risk Continuously, Study Shows
May 8th 2025Previously used to treat HIV and Hepatitis B, nucleoside reverse transcriptase inhibitors (NRTIs) reduced the risk of Alzheimer’s disease by an average of 9% every year, according to new research published in Alzheimer’s and Dementia.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
